Table 1.
Time of assessment and antigen | IgG and IgG subclass levels (EU/ml)a |
|||||||||
---|---|---|---|---|---|---|---|---|---|---|
Total IgG |
IgG1 |
IgG2 |
IgG3 |
IgG4 |
||||||
wP | aP | wP | aP | wP | aP | wP | aP | wP | aP | |
Prebooster (wP, n = 61; aP, n = 61) | ||||||||||
PT | 4.5 | 7.7b | 1.3 | 3.2b | 1.7 | 1.7 | 0.02 | 0.05b | 0.02 | 0.07b |
FHA | 8.8 | 16b | 6.2 | 14b | 0.46 | 0.36 | 0.08 | 0.10 | 0.09 | 0.60b |
Prn | 3.1 | 24b | 1.8 | 20b | 0.28 | 0.36 | 0.07 | 0.18b | 0.02 | 0.67b |
28 days postbooster (wP, n = 52; aP, n = 40) | ||||||||||
PT | 61 | 187b | 38 | 140b | 5.5 | 4.6 | 0.65 | 0.56 | 0.40 | 14b |
FHA | 195 | 521b | 181 | 450b | 2.0 | 8.2b | 1.6 | 2.2 | 3.2 | 36b |
Prn | 187 | 1253b | 178 | 1215b | 1.2 | 3.4b | 1.3 | 1.2 | 1.3 | 18b |
2 yr postbooster (wP, n = 63; aP, n = 61) | ||||||||||
PT | 11c | 26b,c | 5.1c | 16b,c | 1.7 | 2.7 | 0.03 | 0.04 | 0.05c | 0.38b,c |
FHA | 45c | 81b,c | 42c | 75b,c | 0.16d | 0.38b | 0.10 | 0.08 | 0.97c | 2.7b,c |
Prn | 19c | 110b,c | 17c | 103b,c | 0.19 | 0.44b | 0.11 | 0.14 | 0.27c | 2.9b,c |
Data are expressed as geometric mean values specific for PT, FHA, or Prn in children who were primed with either wP or aP. All values for 28 days postbooster were significantly increased (P < 0.05) compared with prebooster levels, and those for 2 years postbooster were significantly decreased (P > 0.05) compared with 28-day postbooster values.
Significantly increased levels in aP-primed children compared to wP-primed children (P < 0.05).
Significantly increased values in children 2 years after booster vaccination compared to prebooster levels (P < 0.05).
Significantly decreased levels in children 2 years after booster vaccination compared to prebooster levels (P < 0.05).